Identify Dry Eye Inflammation with INFLAMMADRY®
InflammaDry® is the first and only, rapid, in-office test that detects MMP-9, an inflammatory marker that is consistently elevated in the tears of patients with dry eye disease.1 Using direct sampling microfiltration technology, InflammaDry® accurately identifies elevated levels of MMP-9 protein in tear fluid samples taken from the inside lining of the lower eyelid, the palpebral conjunctiva.
InflammaDry® is a disposable, low cost test, that requires no additional equipment to administer or interpret results. Using four simple steps, InflammaDry® test results are achieved in just 10 minutes, aiding in the diagnosis of dry eye before the patient leaves the office.
By implementing InflammaDry® into your practice, you can:
Make a rapid, accurate diagnosis before the patient leaves your office
Reduce complications associated with dry eye
Help improve clinical outcomes and patient quality of life3
Identify and treat dry eye disease perioperatively for better surgical outcomes4
 Chotikavanich S, de Paiva CS, Li de Q, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3203-9.  RPS InflammaDry sensitivity and specificity was compared to clinical truth in RPS clinical study : protocol # 100310.  Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology. 2003 Jul;110(7):1412-9.  Sambursky R, O’Brien TP. MMP-9 and the perioperative management of LASIK surgery. Curr Opin Ophthalmol. 2011 Jul;22(4):294-303.